Omega-3 fatty acids may inhibit prostate cancer cell growth
the ONA take:
In contradiction to a 2013 study, researchers have found a mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells. The new study was published in the Journal of Pharmacology and Experimental Therapeutics.
Kathryn Meier, PhD, and two students at Washington State University looked at prostate cell cultures and found that fatty acids are able to bind to FFA4, the “free fatty acid receptor 4”, which inhibits growth factors and suppresses the spread of cancer cells.
“This kind of knowledge could lead us to better treat or prevent cancer because now we know how it works,” Dr. Meier said.
This study contrasts with a 2013 study published in the Journal of the National Cancer Institute which found that men with higher levels of omega-3 fatty acids in their blood had a greater risk of developing prostate cancer.
However, it is still unclear if the effect can be obtained through dietary supplements, and that the drug needs to be in a cancer cell constantly in order to take effect.
A mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|